{"title":"Out-of-pocket costs for long-acting reversible contraception among individuals enrolled in employer sponsored insurance plans.","authors":"Linda Li, Brittni Frederiksen, Alina Salganicoff","doi":"10.1016/j.contraception.2026.111516","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Recent research finds that a significant share of long-acting reversible contraceptive (LARC) users with private insurance incur out-of-pocket costs associated with contraceptive services and supplies, despite the Affordable Care Act's (ACA) requirement that contraceptives be covered without cost-sharing. This analysis aimed to advance our understanding of what contributes to the out-pocket costs for intrauterine device (IUD) and contraceptive implant insertions by looking at all services and costs associated with insertion among privately insured individuals.</p><p><strong>Study design: </strong>Using the 2023 Merative MarketScan Commercial Claims and Encounter Database, a national sample of healthcare claims for people enrolled in employer sponsored insurance plans, we estimated out-of-pocket costs for 98,916 IUD and 30,259 implant insertion encounters among females ages 15-49.</p><p><strong>Results: </strong>Only 2.4% of IUD and 4.0% of implant insertion encounters had out-of-pocket costs related to the LARC device or insertion procedure itself. However, we find that nearly half of IUD (45.7%) and over a third of implant (35.8%) insertion encounters resulted in out-of-pocket expenses for other services commonly provided as part of a LARC insertion, such as pregnancy tests, office visits, ultrasounds, STI tests, and pain medication. Among insertion encounters with cost-sharing, the median out-of-pocket cost was $35.00 (25<sup>th -</sup> 75th percentile: $15.00 - $90.00) for an IUD insertion and $16.88 (25<sup>th -</sup> 75th percentile: $7.75 - $40.00) for an implant insertion.</p><p><strong>Conclusion: </strong>Despite a federal requirement that insurance cover the full cost of contraceptive services and supplies, a sizable share of IUD and contraceptive implant insertions result in out-of-pocket charges for privately insured patients.</p><p><strong>Implications: </strong>While privately insured women rarely pay out-of-pocket for a LARC device or insertion procedure itself, other services commonly provided as part of the LARC insertion often result in out-of-pocket costs, highlighting areas for clearer guidance, stronger oversight, and better patient and provider education on coverage of services related to LARC provision.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"111516"},"PeriodicalIF":2.3000,"publicationDate":"2026-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.contraception.2026.111516","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Recent research finds that a significant share of long-acting reversible contraceptive (LARC) users with private insurance incur out-of-pocket costs associated with contraceptive services and supplies, despite the Affordable Care Act's (ACA) requirement that contraceptives be covered without cost-sharing. This analysis aimed to advance our understanding of what contributes to the out-pocket costs for intrauterine device (IUD) and contraceptive implant insertions by looking at all services and costs associated with insertion among privately insured individuals.
Study design: Using the 2023 Merative MarketScan Commercial Claims and Encounter Database, a national sample of healthcare claims for people enrolled in employer sponsored insurance plans, we estimated out-of-pocket costs for 98,916 IUD and 30,259 implant insertion encounters among females ages 15-49.
Results: Only 2.4% of IUD and 4.0% of implant insertion encounters had out-of-pocket costs related to the LARC device or insertion procedure itself. However, we find that nearly half of IUD (45.7%) and over a third of implant (35.8%) insertion encounters resulted in out-of-pocket expenses for other services commonly provided as part of a LARC insertion, such as pregnancy tests, office visits, ultrasounds, STI tests, and pain medication. Among insertion encounters with cost-sharing, the median out-of-pocket cost was $35.00 (25th - 75th percentile: $15.00 - $90.00) for an IUD insertion and $16.88 (25th - 75th percentile: $7.75 - $40.00) for an implant insertion.
Conclusion: Despite a federal requirement that insurance cover the full cost of contraceptive services and supplies, a sizable share of IUD and contraceptive implant insertions result in out-of-pocket charges for privately insured patients.
Implications: While privately insured women rarely pay out-of-pocket for a LARC device or insertion procedure itself, other services commonly provided as part of the LARC insertion often result in out-of-pocket costs, highlighting areas for clearer guidance, stronger oversight, and better patient and provider education on coverage of services related to LARC provision.